Montelukast v placebo at 12 weeks in children with persistent asthma
| Mean decrease in score from baseline | |||
|---|---|---|---|
| Outcomes§ | Montelukast | Placebo | Least-square mean difference (CI) |
| §No symptoms = 0; severe symptoms = 4 or 5. | |||
| Overall daytime asthma symptom score | 0.37 | 0.26 | 0.12 (0.04 to 0.20) |
| Overnight asthma symptom score | 0.46 | 0.37 | 0.11 (0.01 to 0.21) |